105 related articles for article (PubMed ID: 6701314)
21. 99mTc-neoglycoalbumin (NGA)-binding to human hepatic binding protein (HBP) in vitro.
Virgolini I; Angelberger P; Müller C; O'Grady J; Sinzinger H
Br J Clin Pharmacol; 1990 Feb; 29(2):207-14. PubMed ID: 2306412
[TBL] [Abstract][Full Text] [Related]
22. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
[TBL] [Abstract][Full Text] [Related]
23. Functional liver imaging with 99Tcm-galactosyl-neoglycoalbumin (NGA) in alcoholic liver cirrhosis and liver fibrosis.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Nucl Med Commun; 1991 Jun; 12(6):507-17. PubMed ID: 1866104
[TBL] [Abstract][Full Text] [Related]
24. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
Virgolini I; Müller C; Klepetko W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
Br J Cancer; 1990 Jun; 61(6):937-41. PubMed ID: 2164838
[TBL] [Abstract][Full Text] [Related]
25. [Preparation of hepatic targeting antivirus agent NGA-ACV and its targeting property].
Fan JZ; Li TL; Pang QJ; Guan CT; He Y; Su KY
Yao Xue Xue Bao; 1996; 31(8):585-90. PubMed ID: 9772705
[TBL] [Abstract][Full Text] [Related]
26. Copolymer-based hepatocyte asialoglycoprotein receptor targeting agent for SPECT.
Yang W; Mou T; Shao G; Wang F; Zhang X; Liu B
J Nucl Med; 2011 Jun; 52(6):978-85. PubMed ID: 21571805
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.
Pimstone NR; Stadalnik RC; Vera DR; Hutak DP; Trudeau WL
Hepatology; 1994 Oct; 20(4 Pt 1):917-23. PubMed ID: 7927233
[TBL] [Abstract][Full Text] [Related]
28. [The preparation of hepatic receptor imaging agent 99mTc-DTPA-NGA].
Li Y; Guan C; Wang Q
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):54-8. PubMed ID: 9208621
[TBL] [Abstract][Full Text] [Related]
29. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
Kudo M; Vera DR; Stadalnik RC; Esquivel CO; Trudeau WL; Ikekubo K; Todo A
Dig Dis Sci; 1993 Dec; 38(12):2183-8. PubMed ID: 8261818
[TBL] [Abstract][Full Text] [Related]
30. Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin.
Vera DR; Stadalnik RC; Kudo M; Krohn KA
Methods Enzymol; 1994; 247():402-9. PubMed ID: 7898368
[No Abstract] [Full Text] [Related]
31. In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.
Stadalnik RC; Kudo M; Eckelman WC; Vera DR
Invest Radiol; 1993 Jan; 28(1):64-70. PubMed ID: 8425855
[No Abstract] [Full Text] [Related]
32. Liver function in acute viral hepatitis as determined by a hepatocyte-specific ligand: 99mTc-galactosyl-neoglycoalbumin.
Virgolini I; Müller C; Höbart J; Scheithauer W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
Hepatology; 1992 Apr; 15(4):593-8. PubMed ID: 1551636
[TBL] [Abstract][Full Text] [Related]
33. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
34. Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system.
Vera DR; Krohn KA; Scheibe PO; Stadalnik RC
IEEE Trans Biomed Eng; 1985 May; 32(5):312-22. PubMed ID: 3997184
[No Abstract] [Full Text] [Related]
35. Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.
Gore S; Morris AI; Gilmore IT; Maltby PJ; Thornback JR; Billington D
J Nucl Med; 1991 Mar; 32(3):506-11. PubMed ID: 2005461
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetics of 99m Tc-technephyte in radionuclide studies of the liver and spleen].
Ovdienko NI; Starovoĭtova LP; Kodina GE; Malysheva AO; Tul'skaia TI
Med Radiol (Mosk); 1987 Jul; 32(7):63-7. PubMed ID: 3613926
[TBL] [Abstract][Full Text] [Related]
37. [Characterization of receptor-mediated binding of 99mTc-NGA in vitro].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):22-5. PubMed ID: 8070765
[TBL] [Abstract][Full Text] [Related]
38. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin.
Kudo M; Todo A; Ikekubo K; Yamamoto K; Vera DR; Stadalnik RC
Hepatology; 1993 May; 17(5):814-9. PubMed ID: 8491449
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of a receptor-binding radiopharmacokinetic model.
Vera DR; Stadalnik RC; Metz CE; Pimstone NR
J Nucl Med; 1996 Jan; 37(1):160-4. PubMed ID: 8543988
[TBL] [Abstract][Full Text] [Related]
40. Work in progress: clinical evaluation of Tc-99m-trimethylbromo-IDA and Tc-99m-diisopropyl-IDA for hepatobiliary imaging.
Klingensmith WC; Fritzberg AR; Spitzer VM; Kuni CC; Williamson MR; Gerhold JP
Radiology; 1983 Jan; 146(1):181-4. PubMed ID: 6681569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
